Ted Price, Diana Tavares-Ferreira, and Stephanie Shiers discuss how mapping gene expression at the neuronal level provides insight into pain mechanisms and anti-pain drug development.

Making filtration devices easier to clean reduces fatigue and injury risk while improving reproducibility.

Cammie Lesser will discuss how she turns a probiotic into a drug-delivering machine, while Andrew Y. Koh will describe the connection between the gut microbiota and cancer immunotherapy efficacy.

Drug screening in 3D cell cultures is possible with the right tools.

In this workshop, learn how to use hydrogel 3D cell culture plates for streamlined 3D cell culture colony formation, imaging, metabolic read-out, and T cell-mediated tumor cell killing.

Researchers devise strategies to improve checkpoint inhibitor therapy and predict patient response.

As research and therapeutic applications for pluripotent stem cells (PSCs) grow, so does the need to reliably and cost-effectively generate large numbers of high-quality cells.

Tyson Shepherd will present data from two large-scale screens of libraries developed using the Inscripta Onyx platform.

Jeffrey Weidner and Eric Niederkofler will discuss strategies for optimizing dose response assays.

Download this white paper from Collaborative Drug Discovery to explore how modern informatics systems like CDD Vault^® can provide a cross-domain platform for storage, analysis, and sharing to promote greater collaboration between drug discovery project team members.

Experts will discuss how they use new CRISPR technologies to advance their cell and gene therapy research.

Molly Shoichet and Bridget Wagner discuss strategies for using phenotypic screening to identify novel agents against diseases such as cancer and diabetes.

Download this article to learn how to pick the best detection technique for your protein research!

Erik Steinfelder and Bogi Eliasen will examine the importance of biobanking in precision medicine, from early-stage research to diagnostics and treatments.

The urgent need for tests and therapeutics has brought companies together and pushed researchers to work at breakneck speeds.

The midwestern state has quietly laid the groundwork for a biotech hub.

The East Coast campus of the research institute received shipments of freeze-dried or frozen samples of more than 210,000 microbial strains, which scientists plan to mine for potentially useful natural products.

The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.

Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.